Lemaitre Vascular (LMAT) Accumulated Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Accumulated Expenses data on file, last reported at $3.4 million in Q1 2026.

• Quarterly Accumulated Expenses fell 82.86% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 82.86% YoY) and the FY2025 annual result came in at $29.4 million, up 18.92% from the prior year.
• Accumulated Expenses fell to $3.4 million in Q1 2026 per LMAT's latest filing, from $29.4 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $29.4 million in Q4 2025 and bottomed at $719000.0 in Q3 2025.
• The 5-year median for Accumulated Expenses is $9.9 million (2022), against an average of $12.0 million.
• The widest annual swing landed in 2022, when Accumulated Expenses surged 634.35%; it then sank 96.94% in 2025.
• Tracing LMAT's Accumulated Expenses over 5 years: stood at $20.0 million in 2022, then plunged by 43.67% to $11.2 million in 2023, then surged by 119.88% to $24.7 million in 2024, then rose by 18.92% to $29.4 million in 2025, then tumbled by 88.39% to $3.4 million in 2026.
• Per Business Quant, the three latest LMAT Accumulated Expenses figures stand at $3.4 million (Q1 2026), $29.4 million (Q4 2025), and $719000.0 (Q3 2025).

Peer Comparison